Head-to-Head

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares vs. Eli Lilly & Co.

KNSA

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

$78.13 +1.15%

VS LLY

Eli Lilly & Co.

$1170.14 +0.45%

Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 9 compared factors.

Size & Scale

KNSALLY
Market Cap $6.03 billion $1.04 trillion
Revenue (TTM) $840.85 million $79.67 billion
Net Income (TTM) $80.66 million $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

KNSALLY
P/E Ratio 78.92 39.28
Price / Book 9.21 30.65
Price / Sales 7.17 13.03

KNSA leads on 2 of 3 valuation factors.

Profitability

KNSALLY
Net Margin 9.59% 33.53%
Return on Equity 12.33% 78.84%

LLY leads on 2 of 2 profitability factors.

Dividend

KNSALLY
Dividend Yield — 0.59%
Payout Ratio — 23.23

KNSA and LLY split the dividend factors evenly.

Risk & Sentiment

KNSALLY
Short Interest 0.02% 1.29%

KNSA leads on 1 of 1 risk & sentiment factors.

Dig deeper: KNSA overview, KNSA financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.